Product Information
ROWEEPRA 500 MG TABLET is a generic product labeled by OWP Pharmaceuticals, Inc., priced at $0.0739 per EA under NDC 69102010501. Its NADAC has been published 285 times since Mar 10, 2021.
FDA first approved this application on Jan 15, 2009. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
500 mg/1
Manufacturer
OWP Pharmaceuticals, Inc.NDC
69102010501
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
LEVETIRACETAMApproval Type
Generic (ANDA)
FDA Application
ANDA078858FDA Approved
1/15/2009
TE Code
AB
On Market Since
10/28/2020
Pharmacological Classes
Price Statistics
The NADAC for ROWEEPRA 500 MG TABLET has been published 285 times since Mar 10, 2021, and over the history we have for it it has declined 40.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0739 per EA |
|---|---|
| All-time high | $0.1251 (Aug 11, 2021) |
| All-time low | $0.0608 (Nov 20, 2024) |
| 52-week high | $0.0799 |
| 52-week low | $0.0739 |
| Median price | $0.0902 |
| Average price | $0.0906 |
| Largest weekly change | -26.6% (Nov 20, 2024) |
| Weeks tracked | 285 |
| Tracking since | Mar 10, 2021 |
Generic Alternatives
The matcher finds 20 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 3% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of ROWEEPRA 500 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ROWEEPRA 500 MG TABLET, manufactured by OWP Pharmaceuticals, Inc., is $0.0739 per EA (NDC 69102010501), effective Aug 19, 2026.
How has the price of ROWEEPRA 500 MG TABLET changed over time?
Over the history we have for it, the NADAC for ROWEEPRA 500 MG TABLET has declined 40.2%. It has been tracked across 285 weekly CMS publications since Mar 10, 2021.
What are the highest and lowest recorded NADAC prices for ROWEEPRA 500 MG TABLET?
Since Mar 10, 2021, the NADAC for ROWEEPRA 500 MG TABLET has ranged from a low of $0.0608 (Nov 20, 2024) to a high of $0.1251 (Aug 11, 2021), with a median of $0.0902 per EA.
Are there cheaper alternatives to ROWEEPRA 500 MG TABLET?
Yes. 20 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, LEVETIRACETAM 500 MG TABLET, is $0.0720 per EA — about 3% below ROWEEPRA 500 MG TABLET.
Who manufactures ROWEEPRA 500 MG TABLET?
ROWEEPRA 500 MG TABLET (NDC 69102010501) is labeled by OWP Pharmaceuticals, Inc., and CMS classifies it as a generic product.